Jason D. Ulrich
YOU?
Author Swipe
View article: Lymphoid gene expression supports neuroprotective microglia function
Lymphoid gene expression supports neuroprotective microglia function Open
Microglia, the innate immune cells of the brain, play a defining role in the progression of Alzheimer’s disease (AD) 1 . The microglial response to amyloid plaques in AD can range from neuroprotective to neurotoxic 2 . Here we show that th…
View article: ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease Open
Alzheimer’s disease (AD), the most common cause of dementia, is characterized by the accumulation of amyloid-β (Aβ) in senile plaques and abnormally hyperphosphorylated tau proteins in neurofibrillary tangles. While much of the research ha…
View article: APOE3 Christchurch influences amyloid induced tau seeding and spreading via effects on microglia
APOE3 Christchurch influences amyloid induced tau seeding and spreading via effects on microglia Open
Background A recent case report described an individual who was a homozygous carrier of the APOE3 Christchurch (APOE3ch) mutation and resistant to autosomal dominant Alzheimer’s Disease (AD) caused by a PSEN1‐E280A mutation. Whether APOE3c…
View article: Investigation of Tau as a self‐antigen that drives T cell immunity in a tauopathy mouse model
Investigation of Tau as a self‐antigen that drives T cell immunity in a tauopathy mouse model Open
Background Alzheimer’s disease (AD) is characterized by the aggregation and accumulation of proteins including amyloid‐β and tau. We previously compared the immunological milieus in the brain of mice with amyloid deposition or tau aggregat…
View article: CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly
CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly Open
Background The immune system is substantially involved in the development and progression of age‐related cognitive decline and Alzheimer’s disease (AD). Method As genetic and environmental factors interactively impact these conditions, we …
View article: CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly Open
Background The immune system is substantially involved in the development and progression of age‐related cognitive decline and Alzheimer’s disease (AD). Method As genetic and environmental factors interactively impact these conditions, we …
View article: Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Author Correction: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy Open
View article: Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference Open
INTRODUCTION The apolipoprotein E gene ( APOE ) is an established central player in the pathogenesis of Alzheimer's disease (AD), with distinct apoE isoforms exerting diverse effects. apoE influences not only amyloid‐beta and tau pathologi…
View article: Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist Open
View article: Rapid sequential clustering of NMDARs, CaMKII, and AMPARs upon activation of NMDARs at developing synapses
Rapid sequential clustering of NMDARs, CaMKII, and AMPARs upon activation of NMDARs at developing synapses Open
Rapid, synapse-specific neurotransmission requires the precise alignment of presynaptic neurotransmitter release and postsynaptic receptors. How postsynaptic glutamate receptor accumulation is induced during maturation is not well understo…
View article: CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly
CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly Open
The immune system substantially influences age-related cognitive decline and Alzheimer’s disease (AD) progression, affected by genetic and environmental factors. In a Mayo Clinic Study of Aging cohort, we examined how risk factors like APO…
View article: Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy
Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy Open
Alzheimer’s disease (AD) is characterized by amyloid plaques and neurofibrillary tangles, in addition to neuroinflammation and changes in brain lipid metabolism. 25-Hydroxycholesterol (25-HC), a known modulator of both inflammation and lip…
View article: APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread Open
View article: Microglia‐mediated T cell Infiltration Drives Neurodegeneration in Tauopathy
Microglia‐mediated T cell Infiltration Drives Neurodegeneration in Tauopathy Open
Background Extracellular amyloid‐β (Aβ) deposition as neuritic plaques and intracellular accumulation of hyperphosphorylated, aggregated tau as neurofibrillary tangles (NFT) are two of the characteristic hallmarks in Alzheimer’s disease (A…
View article: Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist Open
View article: IMMU-28. TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS
IMMU-28. TREM2 INHIBITION REPROGRAMS MYELOID CELLS TO STIMULATE ANTI-TUMOR IMMUNITY THROUGH BOTH DIRECT AND INDIRECT MECHANISMS Open
The prevailing view is that myeloid cells—macrophages and microglia—in the tumor microenvironment (TME) are immunosuppressive and promote glioblastoma (GBM) progression. However, myeloid cells have the functional plasticity to restrict or …
View article: Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration Open
Parenchymal border macrophages (PBMs) reside close to the central nervous system parenchyma and regulate CSF flow dynamics. We recently demonstrated that PBMs provide a clearance pathway for amyloid-β peptide, which accumulates in the brai…
View article: APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading
APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading Open
Alzheimer's disease (AD) is the most common cause of dementia. The APOE-ε4 allele of the apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-onset AD. The APOE genotype modulates the effect of sleep disruption on AD …
View article: TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma Open
Triggering receptor expressed on myeloid cells 2 (TREM2) plays important roles in brain microglial function in neurodegenerative diseases, but the role of TREM2 in the GBM TME has not been examined. Here, we found that TREM2 is highly expr…
View article: Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy
Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy Open
View article: Microglia-mediated T cell Infiltration Drives Neurodegeneration in Tauopathy
Microglia-mediated T cell Infiltration Drives Neurodegeneration in Tauopathy Open
Extracellular amyloid-β (Aβ) deposition as neuritic plaques and intracellular accumulation of hyperphosphorylated, aggregated tau as neurofibrillary tangles (NFT) are two of the characteristic hallmarks in Alzheimer’s disease (AD). The reg…
View article: Microglia-mediated T cell Infiltration Drives Neurodegeneration in Tauopathy
Microglia-mediated T cell Infiltration Drives Neurodegeneration in Tauopathy Open
Extracellular amyloid-β (Aβ) deposition as neuritic plaques and intracellular accumulation of hyperphosphorylated, aggregated tau as neurofibrillary tangles (NFT) are two of the characteristic hallmarks in Alzheimer’s disease (AD). The reg…
View article: ApoE isoform– and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy
ApoE isoform– and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy Open
Tau-mediated neurodegeneration is a hallmark of Alzheimer’s disease. Primary tauopathies are characterized by pathological tau accumulation and neuronal and synaptic loss. Apolipoprotein E (ApoE)–mediated neuroinflammation is involved in t…
View article: TREM2 and microglia exosomes: a potential highway for pathological tau
TREM2 and microglia exosomes: a potential highway for pathological tau Open
View article: TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4
TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4 Open
View article: Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading Open
Variants in the triggering receptor expressed on myeloid cells 2 (TREM2) gene are associated with increased risk for late-onset AD. Genetic loss of or decreased TREM2 function impairs the microglial response to amyloid-β (Aβ) plaques, resu…
View article: Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis
Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis Open
View article: Neuronal VCP loss of function recapitulates FTLD-TDP pathology
Neuronal VCP loss of function recapitulates FTLD-TDP pathology Open
The pathogenic mechanism by which dominant mutations in VCP cause multisystem proteinopathy (MSP), a rare neurodegenerative disease that presents as fronto-temporal lobar degeneration with TDP-43 inclusions (FTLD-TDP), remains unclear. To …
View article: Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms
Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms Open
View article: C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation Open